The Patent Finder
PB

Prothera Biologics, Inc.

First filing 2007
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Eight patents currently held, every record listed here

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Sep 2027. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
4
Ending by 2030
Sep 2027
Next term end
5
Patent families

When these terms end

Each bar runs from grant to computed term end. 2015 to 2038.
US RE47,972 Preparation and Composition of Interalpha Inhibitor Proteins from Human Plasma for Therapeutic Use Sep 20, 2027
US 9,758,570 Preparation and Composition of Inter-Alpha Inhibitor Proteins from Blood May 28, 2029
US 10,076,559 Preparation and Composition of Inter-Alpha Inhibitor Proteins from Blood no later than May 28, 2029
US 9,139,641 Preparation and Composition of Inter-Alpha Proteins from Blood Feb 16, 2030
US 9,572,872 Treatment of Disease Using Inter-Alpha Inhibitor Proteins Sep 9, 2033
US 10,258,675 Treatment of Disease Using Inter-Alpha Inhibitor Proteins no later than Sep 9, 2033
US 12,265,090 Inter-Alpha Inhibitor Proteins Apr 25, 2038
US 12,285,471 Methods for Treating Pulmonary Disease Using Inter-Alpha Inhibitor Proteins Jun 5, 2038
20202025203020352038
A dotted end marks a recorded terminal disclaimer this site has not resolved: the term can only be shorter than the bar, never longer.
3 pending applications: term is not computable until grant.Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 22, 2027
    The maintenance fee for Preparation and Composition of Inter-Alpha Proteins from Blood (US 9,139,641) comes due Mar 22, 2027. Unpaid by Sep 22, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 8 of 8

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US RE47,972Preparation and Composition of Interalpha Inhibitor Proteins from Human Plasma for Therapeutic Use
In force
 · Low confidence
In forceLow confidence
US 9,758,570Preparation and Composition of Inter-Alpha Inhibitor Proteins from Blood
In force
 · High confidence
In forceHigh confidence
US 10,076,559Preparation and Composition of Inter-Alpha Inhibitor Proteins from Blood
In force
 · Medium confidence
In forceMedium confidence
US 9,139,641Preparation and Composition of Inter-Alpha Proteins from Blood
In force
 · High confidence
In forceHigh confidence
US 9,572,872Treatment of Disease Using Inter-Alpha Inhibitor Proteins
In force
 · High confidence
In forceHigh confidence
US 10,258,675Treatment of Disease Using Inter-Alpha Inhibitor Proteins
In force
 · Medium confidence
In forceMedium confidence
US 12,265,090Inter-Alpha Inhibitor Proteins
In force
 · High confidence
In forceHigh confidence
US 12,285,471Methods for Treating Pulmonary Disease Using Inter-Alpha Inhibitor Proteins
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 8: 1 patent ended · 3 applications pending · 8 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited